TNF and psoriasis: Currently, four classes of biologics (TNF inhibitors, IL-12/23 inhibitors, IL-17 inhibitors, and IL-23 inhibitors) represent one of the most significant therapeutic advancements in the field of dermatology, which have achieved satisfactory treatment effects (PASI75, PASI90, and even PASI100) among psoriasis patients24.